Call Options

6 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q1 2021

May 12, 2021

SELL
$3.2 - $16.51 $640,000 - $3.3 Million
-200,000 Closed
0 $0
Q3 2020

Nov 16, 2020

BUY
$3.03 - $5.48 $209,070 - $378,120
69,000 Added 52.67%
200,000 $782,000
Q2 2020

Feb 12, 2021

BUY
$3.53 - $6.17 $457,805 - $800,187
129,690 Added 9900.0%
131,000 $694,000
Q2 2020

Aug 14, 2020

SELL
$3.53 - $6.17 $447,215 - $781,677
-126,690 Reduced 98.98%
1,310 $29,000
Q1 2020

Feb 12, 2021

BUY
$3.53 - $12.21 $447,321 - $1.55 Million
126,720 Added 9900.0%
128,000 $531,000
Q1 2020

May 15, 2020

BUY
$3.53 - $12.21 $4,518 - $15,628
1,280 New
1,280 $70,000

Others Institutions Holding EOLS

About Evolus, Inc.


  • Ticker EOLS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 56,094,800
  • Market Cap $608M
  • Description
  • Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. The company was incorp...
More about EOLS
Track This Portfolio

Track Pura Vida Investments, LLC Portfolio

Follow Pura Vida Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pura Vida Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pura Vida Investments, LLC with notifications on news.